Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has John Lister's publication output changed over time?
ScholarIQpublication output · 1964–2012
Output grew100% over the shown period — from 1 works in 1964 to 2 in 2012.
1
1
1
3
1
1
1
2
19641981198419981999200320072012
What are the most-cited papers on John Lister?
ScholarIQmost cited works
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Peter McLaughlin, A.J. Grillo-López, Brian K. Link, Ronald Levy, M. S. Czuczman, Michael E. Williams, Meyer R. Heyman, Isabelle Bence‐Bruckler, Christine A. White, Fernando Cabanillas, Vinay Jain, Anthony D. Ho, John Lister, Ken Wey, Diying Shen, B.K. Dallaire
Journal of Clinical Oncology. 19982,762 Citations
Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases
Thomas J. Walsh, John W. Hiemenz, Nita L. Seibel, John R. Perfect, Gary Horwith, Lily Lee, Jeffrey L. Silber, Mark J. DiNubile, Annette C. Reboli, Eric J. Bow, John Lister, Elias Anaissie
S72350973. 1998626 CitationsOPEN ACCESS
EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS
A N Gorsuch, John Lister, B.M. Dean, K.M. Spencer, J. M. McNally, G. F. Bottazzo, A G Cudworth
The Lancet. 1981483 Citations
Posterior reversible encephalopathy syndrome in infection, sepsis, and shock.
Walter S. Bartynski, J F Boardman, Zella R. Zeigler, Richard K. Shadduck, John Lister
PubMed. 2007396 CitationsOPEN ACCESS
Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven Aspergillosis
John R. Wingard, Paul Kubilis, Lily Lee, Gary C. Yee, Mary H. White, Walshe Louise, Raleigh A. Bowden, Elias Anaissie, John Hiemenz, John Lister
S72350973. 1999365 CitationsOPEN ACCESS
Related on ScholarIQ
Allegheny Health Network
Institution
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Paper
Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases
Paper
EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS
Paper
Posterior reversible encephalopathy syndrome in infection, sepsis, and shock.
Paper
Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven Aspergillosis
Paper